Skip to main content

Table 1 Baseline characteristics

From: Clinical results of multidisciplinary therapy including palliative posterior spinal stabilization surgery and postoperative adjuvant therapy for metastatic spinal tumor

Characteristic

Value

Patients, n

55

Age at surgery, mean (range), years

66.8 (26–92)

Sex, n (%)

 Male

37 (67.2)

 Female

18 (32.7)

Metastatic tumor diagnosis, n (%)

 

 Lung

11 (20.0)

 Liver

9 (16.3)

 Prostate

6 (10.9)

 Myeloma

5 (9.0)

 Kidney

4 (7.2)

 Thyroid

4 (7.2)

 Lymphoma

3 (5.4)

 Gallbladder

3 (5.4)

 Breast

2 (3.6)

 Sarcoma

2 (3.6)

 Others

5 (9.0)

 Unknown

1 (1.8)

Main level of tumors, n (%)

 Cervical

9 (16.3)

 Thoracic

32 (58.1)

 Lumbar

14 (25.4)

Preoperative modified Frankel category, n (%)

 A

2 (3.6)

 B

1 (1.8)

 C

19 (34.5)

 D1

15 (27.2)

 D2

1 (1.8)

 D3

10 (18.1)

 E

7 (12.7)

Visual analogue scale (range)

4.6 (1–10)

Tokuhashi score, n (%)

 0–8

40 (72.7)

 9–11

9 (16.3)

 12–15

6 (10.9)

Spinal instability neoplastic score, n (%)

 0–6

6 (10.9)

 7–12

48 (87.2)

 13–18

1 (1.8)

Epidural spinal cord compression scale, n (%)

 0

1 (1.8)

 1a

4 (7.2)

 1b

4 (7.2)

 1c

3 (5.4)

 2

23 (41.8)

 3

20 (36.3)

Preoperative Barthel index, mean (range)

48.7 (0–100)